u/cohhen

5 theses · first seen Oct 20, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d000———
3d000———
1w111100%+0.7%+0.7%
1m1100%-23.7%-23.7%
3m1100%-45.9%-45.9%
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ENVXr/pennystocksDDbullish
u/cohhen · 123d ago4 prior · 0% at 3mo

$ENVX — The Next 300% Runner: MAR to JUL 2026 Catalysts (A Routine Runner)

Enovix has demonstrated a consistent pattern of 300%+ rallies in July-August over the past four years, driven by production milestones, customer announcements, and operational breakthroughs. With Fab-2 ramping in Malaysia through 2026, a lead smartphone OEM partnership with Honor targeting 2H 2026 deployment, and AI-1 battery adoption accelerating due to on-device AI power demands, the company is positioned for a similar seasonal surge in the coming period.

At post $5.36Now $3.00-44.0% since posted1m ago
1d—
3d—
1w+0.7%
1m-23.7%
3m-45.9%
6m—
1y—
original post →
$DFLIr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄bullish
u/cohhen · 383d ago4 prior · 0% at 3mo

$DFLI TO $3.00 EOD: Granted Patent

Dragonfly Energy received a USPTO patent allowance for its battery communication technology covering mesh networking and data propagation. The patent strengthens the company's IP portfolio and is linked to its Battle Born HUB product, positioning the company for growth.

At post $157.60Now $1.84-98.8% since posted1m ago
1d-32.5%
3d-31.0%
1w-43.1%
1m-58.9%
3m-80.1%
6m-89.4%
1y-85.2%
original post →
$MNTSr/pennystocksDDbullish
u/cohhen · 388d ago4 prior · 0% at 3mo

Today's Dips Are Blessings In Disguise: $GPUS; $INTS; $MNTS; $MIST

MNTS is a commercial space infrastructure company developing in-space transportation vehicles and hosted payload services; recent NASA contract wins ($2.5M thruster, $5.1M materials production) validate its technology and provide non-dilutive funding. Operating leverage in space logistics and a low-tens-of-millions market cap create significant upside potential if OSV deployments and recurring payload revenue execute.

At post $24.46live price unavailable
1d—
3d+4.4%
1w-2.9%
1m-32.3%
3m-47.4%
6m-85.1%
1y-86.6%
original post →
$INTSr/pennystocksDDbullish
u/cohhen · 388d ago4 prior · 0% at 3mo

Today's Dips Are Blessings In Disguise: $GPUS; $INTS; $MNTS; $MIST

INTS is a late-stage biotech with its DfuseRx platform combining localized chemotherapy and immune activation, running Phase 3 STS and Phase 2 TNBC trials with prior data showing mOS of 21.3 months versus 6.7 months control. At ~$15–16M market cap with readouts expected through 2026, the company presents asymmetric upside if trials succeed or partnership/funding catalysts accelerate.

At post $7.63Now $3.47-54.5% since posted1m ago
1d—
3d-1.6%
1w-14.4%
1m+49.2%
3m+42.3%
6m-27.9%
1y-52.4%
original post →
$GPUSr/pennystocksDDbullish
u/cohhen · 388d ago4 prior · 0% at 3mo

Today's Dips Are Blessings In Disguise: $GPUS; $INTS; $MNTS; $MIST

GPUS is transforming into an AI data infrastructure and Bitcoin mining operator with a cleaned balance sheet ($30M debt elimination), dual revenue streams, and an existing 617,000 sq ft facility being expanded. The company has ordered 1,000 Bitcoin miners scaling to 5,000 units (20MW) while pursuing a $100M on-balance-sheet Bitcoin treasury strategy, presenting a significant valuation disconnect given the micro-cap ($12M) versus Bitcoin holdings alone.

At post $2.40Now $0.16-93.2% since posted1m ago
1d—
3d-10.4%
1w-33.3%
1m-22.9%
3m-25.0%
6m-70.8%
1y-93.5%
original post →

End of results.